Tissue penetration device

US9427532B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9427532-B2
Application numberUS-201414500497-A
CountryUS
Kind codeB2
Filing dateSep 29, 2014
Priority dateJun 12, 2001
Publication dateAug 30, 2016
Grant dateAug 30, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An agent injection device is provided that is capable of injecting an agent to a known predetermined tissue depth. An injection member has an elongate injection shaft with an outlet port configured to dispense an agent at a controllable time. A controllable driver is coupled to the elongate injection shaft and is configured to drive the injection member into target tissue. A velocity control system is in communication with the controllable driver and is configured to control the velocity of the elongate injection shaft.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of injecting an agent into the tissue of a patient at a known predetermined depth, comprising: driving an elongate injection shaft using an electronic driver, the elongated injection shaft having an outlet port configured to dispense an agent at a controllable time toward the patient's target tissue; providing programmable control of the electronic driver for a desired velocity of the injection shaft; advancing the elongate injection shaft into the target tissue from the contact point over a displacement equal to the sum of an elastic recoil displacement value for the target tissue, the distance between a distal extremity of the elongate injection shaft and the outlet port, and the desired tissue depth of injection for agent deposition; injecting the agent; and accurately delivering the agent to a specific depth within a skin or tissue layer and provide for localized agent delivery; and further comprising: using a plurality of agent injection modules; and providing a series of metered doses of the agent. 2. The method of claim 1 , further comprising: using a rapid insertion velocity to the specific depth to reduce pain of insertion of the needle into the skin. 3. The method of claim 1 , further comprising: using a position feedback loop of the driver coupled to the elongate injection shaft. 4. The method of claim 1 , further comprising: using an agent injection module that has a reservoir.

Assignees

Inventors

Classifications

  • by compression of deformable ampoule or carpule wall · CPC title

  • Magazines with multiple ampoules directly inserted into an injection or infusion device, e.g. revolver-like magazines containing ampoules with or without needles · CPC title

  • A61M5/46Primary

    having means for controlling depth of insertion · CPC title

  • by percutaneous method, e.g. by lancet · CPC title

  • Evaluating skin mechanical properties, e.g. elasticity, hardness, texture, wrinkle assessment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9427532B2 cover?
An agent injection device is provided that is capable of injecting an agent to a known predetermined tissue depth. An injection member has an elongate injection shaft with an outlet port configured to dispense an agent at a controllable time. A controllable driver is coupled to the elongate injection shaft and is configured to drive the injection member into target tissue. A velocity control sy…
Who is the assignee on this patent?
Sanofi Aventis Deutschland
What technology area does this patent fall under?
Primary CPC classification A61M5/46. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).